Core Viewpoint - Health Road Co., Ltd. has seen a significant increase in shareholder confidence following the acquisition of additional shares by major shareholder MayJyu Limited, indicating a potential revaluation of the company's AI healthcare business segment [1][2]. Group 1: Shareholder Activity - MayJyu Limited increased its stake by acquiring 842,000 ordinary shares at an average price of HKD 5.5179 per share, totaling approximately HKD 4.6461 million [1]. - Following this acquisition, MayJyu Limited's total shareholding rose to 44.0575 million shares, representing a 5.02% ownership stake in the company [1]. Group 2: Financial Performance - The company's mid-year performance report for 2025 is expected to be a key factor in the increased shareholder confidence, showcasing significant improvements in operational efficiency [1]. - Health Road's gross margin increased by 1.2 percentage points, and the company turned a profit, shifting its focus from scale expansion to quality of earnings [1]. Group 3: AI Technology and Market Potential - Health Road's self-developed "Medical AI Intelligent Body" has successfully reduced labor costs by 60% for health management chains and doubled customer repurchase rates, demonstrating the commercial viability of its AI technology [2]. - The integration of AI technology with healthcare scenarios is anticipated to enhance monetization opportunities for both C-end and B-end markets, driving an increase in conversion rates [2]. - The company connects over 12,000 hospitals and 210 million users, creating a significant ecological barrier that supports its business model [2].
健康之路获股东增持84.2万股普通股股份